Abstract: Use of galactose or a galactooligosaccharide, for increasing serpin protein production in Bifidobacterium longum subsp. longum.

Abstract: Serpin protein producing Bifidobacterium longum subsp. longum and compositions thereof for use in inhibiting gluten digestion. Compositions comprising the serpin protein producing Bifidobacterium longum subsp. longum may be used to mitigate the effects of hidden gluten in individuals following a gluten free diet.

Abstract: This invention relates to a preparation comprising a probiotic bacterial strain and a prebiotic mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide selected from the group consisting of Ga1NAc?1-3Ga1?1-4G1c, Ga1?1-6Ga1Nac?1-3Ga1?1-4G1c and combinations thereof, 20-95 wt % of at least one neutral oligosaccharide selected from the group consisting of Gal?1-6Gal, Gal?1-6Gal?1-4Glc, Gal?1-6Gal?1-6Glc, Gal?1-3Gal?1-3Glc, Gal?1-3Gal?1-4Glc, Gal?1-6Gal?1-6Gal?1-4Glc, Gal?1-6Gal?1-3Gal?1-4Glc, Gal?1-3Gal?1-6Gal?1-4Glc, Gal?1-3Gal?1-3Gal?1-4Glc and combinations thereof and 2-50 wt % of at least one sialylated oligosaccharide selected from the group consisting of NeuAc?2-3Gal?1-4Glc, NeuAc?2-6Ga1?1-4G1c and combinations thereof. The invention extends to food products comprising said preparation and to the use of the preparation in the prevention and treatment of infections.

Abstract: This invention relates to a preparation comprising a probiotic bacterial strain and a prebiotic mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide selected from the group consisting of GalNAc?1-3Gal ?1-4Glc, Gal ?1-6GalNac?1-3Gal ?1-4Glc and combinations thereof, 20-95 wt % of at least one neutral oligosaccharide selected from the group consisting of Gal?1-6Gal, Gal?1-6Gal?1-4Glc, Gal?1-6Gal?1-6Glc, Gal?1-3Gal?1-3Glc, Gal?1-3Gal?1-4Glc, Gal?1-6Gal?1-6Gal?1-4Glc, Gal?1-6Gal?1-3Gal?1-4Glc, Gal?1-3Gal?1-6Gal?1-4Glc, Gal?1-3Gal?1-3Gal?1-4Glc and combinations thereof and 2-50 wt % of at least one sialylated oligosaccharide selected from the group consisting of NeuAc?2-3Gal?1-4Glc, NeuAc?2-6Gal?1-4Glc and combinations thereof. The invention extends to food products comprising said preparation and to the use of the preparation in the prevention and treatment of infections.

Abstract: This invention relates to a preparation comprising a probiotic bacterial strain and a prebiotic mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide selected from the group comprising Ga1NAc?1,3Ga1?1,4G1c and Ga1?1,6Ga1NAc?1,3Ga1?1,4G1c, 20-95 wt % of at least one neutral oligosaccharide selected from the group comprising Ga1?1,6Ga1, Ga1?1,6Ga1?1,4G1c Ga1?1,6Ga1?1,6G1c, Ga1?1,3Ga1?1,3G1c, Ga1?1,3Ga1?1,4G1c, Ga1? 1,6Ga1? 1,6Ga1? 1,4GIc, Ga1? 1,6Ga1? 1,3Ga1? 1,4GIc Ga1? 1,3Ga1? 1,6Ga1? 1,4GIc and Ga1?1,3Ga1?1,3Ga1?1,4G1c and 2-50 wt % of at least one sialylated oligosaccharide selected from the group comprising NeuAc?2,3Ga1?1,4G1c and NeuAc?2,6Ga1?1,4G1c. The invention extends to food products comprising said preparation and to the use of the preparation in the prevention and treatment of infections.

Abstract: This invention relates to a preparation comprising a probiotic bacterial strain and a prebiotic mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide selected from the group comprising Ga1NAc?1,3Ga1?1,4G1c and Ga1?1,6Ga1NAc?1,3Ga1?1,4G1c, 20-95 wt % of at least one neutral oligosaccharide selected from the group comprising Ga1?1,6Ga1, Ga1?1,6Ga1?1,4G1c Ga1?1,6Ga1?1,6G1c, Ga1?1,3Ga1?1,3G1c, Ga1?1,3Ga1?1,4G1c, Ga1? 1,6Ga1? 1,6Ga1? 1,4G1c, Ga1? 1,6Ga1? 1,3Ga1? 1,4GIc Ga1? 1,3Ga1? 1,6Ga1? 1,4GIc and Ga1?1,3Ga1?1,3Ga1?1,4G1c and 2-50 wt % of at least one sialylated oligosaccharide selected from the group comprising NeuAc?2,3Ga1?1,4G1c and NeuAc?2,6Ga1?1,4G1c. The invention extends to food products comprising said preparation and to the use of the preparation in the prevention and treatment of infections.